MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Differentially expressed miRNAs in retinoblastoma	https://doi.org/10.1016/j.gene.2012.09.129	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia	https://doi.org/10.26355/eurrev_201910_19159	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p	https://doi.org/hsa-mir-488-3p	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Diagnostic and prognostic relevance of serum miR-195 in pediatric acute myeloid leukemia	https://doi.org/10.3233/CBM-170327	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting ?-catenin and Wnt signaling	https://doi.org10.1002/hep4.1029	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study	https://doi.org/10.1016/j.jpedsurg.2016.02.091	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation	https://doi.org/10.3324/haematol.2012.070664	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA	https://doi.org/10.26355/eurrev_201906_18202	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential	https://doi.org/10.1016/j.prp.2017.06.017	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Prognostic value of miR-29a expression in pediatric acute myeloid leukemia	https://doi.org/10.1016/j.clinbiochem.2012.09.002	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MiR-194-5p inhibited metastasis and EMT of nephroblastoma cells through targeting Crk.	https://doi.org/10.1002/kjm2.12180	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization	https://doi.org/10.1371/journal.pone.0052397	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Identification of the transcription factor HOXB4 as a novel target of miR-23a	https://doi.org/10.1002/gcc.22066	2013	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms.	https://doi.org/10.1093/carcin/bgs126	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.	https://doi.org/10.1016/j.gene.2019.01.003	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia	https://doi.org/10.4161/auto.29592	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.	https://doi.org/10.1111/j.1365-2141.2011.08812.x	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia	https://doi.org/10.3233/CBM-170657	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.	https://doi.org/10.1097/MPH.0000000000000921	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.	https://doi.org/10.1111/cas.12370	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View

Publications